wan asyraf

stroke neurologist in Kuala Lumpur, interest in stroke prevention, hyperacute stroke protocol and imaging, stroke rehabilitation

[wan asyraf @DrAsyraf]

@ShadiYaghi2 @NAsdaghi @almuftifawaz @eytanraz interesting mentioned, from our analyses (ongoing) if there is no contraindication LVO with low NIHSS (0-5) with no contraindication for lytic especially in the event likely ICAD lytic performed well (maybe Asia and different etiology less CE)

[World Stroke Org @WorldStrokeOrg]

Want to connect, share, and lead in the field of #neurology?

Exhibit with purpose. #WSC2025 provides your brand with space that matches your identity – choose between shell scheme rentals or space-only booths tailored to your goals. Get in touch and select the setup that feels like home. 🔗 Book your spot now: https://t.co/yyNXAMuJtq
#WSO #StrokeCongress #StrokeCare #StrokeResearch #ExhibitionOpportunities

[World Stroke Org @WorldStrokeOrg]

#WSC2025 Program Highlights: Life After Stroke

💠Creative approaches to life after stroke support.
💠Are we actually making a difference in addressing inequities in the after-stroke support?
💠World Stroke Organization & International Stroke Recovery and Rehabilitation Alliance – Involving people with lived experience in research.

📅Thursday, 23 October 2025 |📍Room 114

This is your chance to engage with trailblazers in the field, discuss the most current challenges and #solutions, and be part of a global movement to transform stroke prevention and treatment. 🔗Find out more: https://t.co/eV10I0QSAz

💡 Gain access to the latest stroke research, connect with top experts, and discover new breakthroughs in treatment and care. 🎟 Register now: https://t.co/uXoKbKjkRV
#WSC2025 #StrokeResearch #WorldStrokeCongress

[World Stroke Academy @WorldStrokeEd]

Upcoming webinar on #Moyamoya disease:🗓️Aug 18th, 2-3pm (CEST)

Chair: @jeyaraj_pandian

✅ Clinical Presentation of Moyamoya
✅ Surgical treatment of Moyamoya
✅ Pressure measurement in Moyamoya bypass

𝐑𝐄𝐆𝐈𝐒𝐓𝐄𝐑: https://t.co/ETiUBttFIs

#StrokeEducation @WorldStrokeOrg

[wan asyraf @DrAsyraf]

@Ash_Shoamanesh My deepest condolences Ashkan

[sheila martins @sheilambrasil]

We are waiting for you in Barcelona!

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: Among patients with BAO and an NIHSS ≤10, there were no significant differences in functional outcomes and mortality at 1 year between BMM+EVT vs BMM alone. #AHAJournals https://t.co/1pbBpGbteh

[SVIN @svinsociety]

#ResearchTuesday

Use of IVT in pts with carotid dissection and moderate AIS but without Afib have better odds of home discharge. #SkimwithSVIN @JAHA_AHA @ShadiYaghi2 @NguyenThanhMD @eva_mistry @JimSiegler https://t.co/jGUyQq8z2Y

@SVINJournal

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: FLAIR vascular hyperintensities (FVH) on MRI are associated with infarct size and functional outcomes among children with acute ischemic stroke. #AHAJournals https://t.co/eQHuHyrS6G

[World Stroke Academy @WorldStrokeEd]

#MondayTip
The "new" (okay, not-so-new) kids on the block
☝️TNK is not the only contender looking to replace alteplase
🇨🇳 Two recent RCTs from China have assessed the efficacy and safety of alternative thrombolytics:
👉 #Prourokinase
👉 #Reteplase
Both with promising results👀

[wan asyraf @DrAsyraf]

@Ahmednasr_Neuro @WorldStrokeOrg superb bro!!

[AshuJadhav @AshuPJadhav]

Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy | Stroke https://t.co/1bHShY6bgR

[wan asyraf @DrAsyraf]

@AzmilAbdulRahim Eid mubarak brother!!

[Shadi Yaghi @ShadiYaghi2]

Not all hypodensity/ASPECTS is the same in large core. In SELECT-2, if ≥26 mL of brain tissue has ≤26 HU (severe hypodensity), there may be no benefit from EVT in large core patients & increased complications @NguyenThanhMD @amrsarrajMD @StrokeAHA_ASA https://t.co/RekCZHSbiZ

[wan asyraf @DrAsyraf]

@lukanisman Selamat Hari Raya Aidilfitri Dato @lukanisman

[Umberto Pensato @UPensato]

Is submaximal angioplasty an effective preventive treatment for severe ICAS? Please take a look at our critique on @StrokeAHA_ASA @GeoffreyDonnan Andrew Demchuk https://t.co/eGgHr6BIUT

[Shadi Yaghi @ShadiYaghi2]

A STOP-CAD secondary analysis engineered by @drmandel : Among high risk features identified in cervical artery dissection, only occlusive dissection seemed to benefit from anticoagulation. Important information for future trials. https://t.co/xBV9lhK7fK @StrokeAHA_ASA 🛑CAD

[International Journal of Stroke @IntJStroke]

Just Accepted!
🧠New study shows stroke etiology was associated with tirofiban efficacy in acute ischemic stroke without endovascular treatment

Read more here👇
https://t.co/pPZkpNNnit @WenboZhaoXWH

[sheila martins @sheilambrasil]

Can you imagine the impact of the world's leading stroke societies and industry partners joining forces?

We have united our voices, knowledge, and strength to face this devastating disease—one that claims lives and leads to lasting disabilities.

The Global Stroke Action Coalition is working tirelessly to place stroke on the global health agenda and ensure that prevention and care are accessible to all.

#StrokeActionNow

https://t.co/0J3geAHLsY

@WorldStrokeOrg
@ESOstroke @AHAScience @TheStrokeAssoc @MarchofDimes @svinsociety @Medtronic @Bayer @Philips @Boehringer #Ipsen #APSO #HeartandStrokeSouthAfrica

[Ahmed Nasreldein @Ahmednasr_Neuro]

Thrilled to share that our manuscript accepted.We hope that our work contributes meaningfully to the outstanding research published in this field.@WorldStrokeOrg @ESOstroke @AfricanStroke @StrokeMena @sheilambrasil @Simona_Sacco_ @NguyenThanhMD @DrAsyraf @Mahmoudneuro @HMasoud_